SCHEMBL20865151

SCHEMBL20865151

C[C@H]1CCCC[C@H]1CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20865150 1.00 — —
SCHEMBL8005132 1.00 — —
SCHEMBL13168480 1.00 — —
SCHEMBL23075077 1.00 — —
SCHEMBL4185496 1.00 — —
SCHEMBL24862084 1.00 — —
SCHEMBL20865148 1.00 — —
Hydrochloric Acid SCHEMBL7213381 0.97 CA1 (0.38) —
SCHEMBL23895433 0.97 CA1 (0.38) —
SCHEMBL21252681 0.97 CA1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701354-B2 Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors D. E. SHAW RESEARCH, LLC (US) 2023-07-18 — — US disclosed
WO-2019183364-A1 PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2019-09-26 — — WO disclosed
WO-2019067843-A1 PYRAZOLO[3,4-B]PYRAZINE DERIVATIVES AS SHP2 PHOSPHATASE INHIBITORS RELAY THERAPEUTICS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback